Stephen E. Lipshultz

Stephen E. Lipshultz's AcademicInfluence.com Rankings

Philosophy

#5792

World Rank

#8692

Historical Rank

Logic

#3007

World Rank

#4099

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Stephen E. Lipshultz's Degrees

Masters Medicine University of Miami
Masters Public Health University of Miami

Why Is Stephen E. Lipshultz Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Stephen E. Lipshultz's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 (2012) (11746)
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 (2012) (9252)
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 (2012) (8152)
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 (2012) (7185)
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015) (5270)
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) (4293)
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013 (2015) (4152)
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. (2013) (2142)
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition (2015) (1618)
Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) (1580)
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015) (1475)
Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. (1991) (1336)
Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2014) (1271)
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015) (1241)
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010 (2012) (1159)
Incidence, causes, and outcomes of dilated cardiomyopathy in children. (2006) (858)
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2014) (853)
Health Effects of Energy Drinks on Children, Adolescents, and Young Adults (2011) (779)
The incidence of pediatric cardiomyopathy in two regions of the United States. (2003) (726)
Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. (1995) (710)
Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2014) (673)
Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) (623)
Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. (2005) (622)
The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. (2004) (563)
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015 (2016) (549)
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) (495)
Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013: Findings From the Global Burden of Disease 2013 Study. (2016) (475)
Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. (2004) (465)
Radiation-associated cardiovascular disease. (2003) (464)
Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015 (2017) (452)
Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience. (1997) (450)
Protecting against anthracycline‐induced myocardial damage: a review of the most promising strategies (2005) (431)
Anthracycline cardiotoxicity: from bench to bedside. (2008) (420)
Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015 (2016) (394)
Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia. (2007) (387)
Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury. (1997) (375)
Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions A Scientific Statement From the American Heart Association (2013) (368)
Anthracycline-Associated Cardiotoxicity in Survivors of Childhood Cancer (2011) (337)
Epidemiology and Cause-Specific Outcome of Hypertrophic Cardiomyopathy in Children: Findings From the Pediatric Cardiomyopathy Registry (2007) (336)
Epidemiology of anthracycline cardiotoxicity in children and adults. (1998) (335)
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion group. (2004) (333)
Systematic Review and Meta-analysis of Circulatory Disease from Exposure to Low-Level Ionizing Radiation and Estimates of Potential Population Mortality Risks (2012) (309)
Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes. (2012) (284)
Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management (2007) (277)
The Safety of Ingested Caffeine: A Comprehensive Review (2017) (277)
Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer. (2002) (275)
Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--Dana-Farber Cancer Institute ALL Consortium Protocol 00-01. (2013) (259)
State of the Science Conference: Initiative to Decrease Cardiovascular Risk and Increase Quality of Care for Patients Living With HIV/AIDS Executive Summary (2008) (251)
Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin. (1999) (215)
Radiation-associated cardiovascular disease: manifestations and management. (2003) (214)
Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial. (2010) (213)
Anthracycline-induced cardiotoxicity in children and young adults. (1998) (199)
Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children's oncology group. (2012) (193)
Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry. (2008) (189)
Cardiovascular manifestations of HIV infection. (1996) (188)
Treatment-related cardiotoxicity in survivors of childhood cancer (2013) (183)
Doxorubicin administration by continuous infusion is not cardioprotective: the Dana-Farber 91-01 Acute Lymphoblastic Leukemia protocol. (2002) (176)
Left ventricular structure and function in children infected with human immunodeficiency virus: the prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group. (1998) (173)
Anthracycline associated cardiotoxicity in survivors of childhood cancer (2007) (171)
A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425. (2009) (171)
The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years. (2010) (171)
Maternal age and other predictors of newborn blood pressure. (2004) (168)
Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial. (2015) (166)
Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer. (2016) (160)
Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404). (2011) (159)
Clinical approach to genetic cardiomyopathy in children. (1996) (156)
Initial congestive heart failure, six to ten years after doxorubicin chemotherapy for childhood cancer. (1990) (155)
Pediatric Cardiomyopathies. (2017) (153)
Cardiac Dysfunction and Mortality in HIV-Infected Children: The Prospective P2C2 HIV Multicenter Study (2000) (150)
Anthracycline-Induced Cardiotoxicity: A Review of Pathophysiology, Diagnosis, and Treatment (2014) (150)
Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapy. (2012) (146)
Use of cardiac troponin T levels as an indicator of doxorubicin-induced cardiotoxicity. (1998) (144)
Outcomes of Restrictive Cardiomyopathy in Childhood and the Influence of Phenotype: A Report From the Pediatric Cardiomyopathy Registry (2012) (143)
Diltiazem treatment for pre-clinical hypertrophic cardiomyopathy sarcomere mutation carriers: a pilot randomized trial to modify disease expression. (2015) (142)
Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy Registry (2013) (140)
Incidence of and risk factors for sudden cardiac death in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry. (2012) (136)
Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children's Oncology Group Randomized Trial Pediatric Oncology Group 9404. (2016) (135)
Cardiotoxicity in childhood cancer survivors: strategies for prevention and management. (2012) (134)
Absence of cardiac toxicity of zidovudine in infants. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study Group. (2000) (134)
Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes (2012) (133)
Competing Risks for Death and Cardiac Transplantation in Children With Dilated Cardiomyopathy: Results From the Pediatric Cardiomyopathy Registry (2011) (133)
Impact of HIV and highly active antiretroviral therapy on leukocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosis. (2006) (129)
Cardiomyopathy in Children: Classification and Diagnosis: A Scientific Statement From the American Heart Association. (2019) (129)
Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation. (2004) (128)
Cardiovascular manifestations of human immunodeficiency virus infection in infants and children. (1989) (127)
Cardiovascular abnormalities in infants prenatally exposed to cocaine. (1991) (126)
Cardiomyopathy Phenotypes and Outcomes for Children With Left Ventricular Myocardial Noncompaction: Results From the Pediatric Cardiomyopathy Registry. (2015) (126)
Factors Associated With Establishing a Causal Diagnosis for Children With Cardiomyopathy (2006) (126)
Effects of HIV infection and antiretroviral therapy on the heart and vasculature. (2008) (125)
Duration of ruptured membranes and vertical transmission of HIV-1: a meta-analysis from 15 prospective cohort studies (2001) (125)
Outcomes in children with Noonan syndrome and hypertrophic cardiomyopathy: a study from the Pediatric Cardiomyopathy Registry. (2012) (125)
Ventricular Remodeling and Survival Are More Favorable for Myocarditis Than For Idiopathic Dilated Cardiomyopathy in Childhood: An Outcomes Study From the Pediatric Cardiomyopathy Registry (2010) (125)
Cardiotoxicity after childhood cancer: beginning with the end in mind. (2010) (123)
Cardiac morbidity and related mortality in children with HIV infection. (1993) (122)
Exposure to anthracyclines during childhood causes cardiac injury. (2006) (119)
Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxane. (2008) (118)
Pathogenesis of HIV-associated cardiovascular complications. (2001) (117)
The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin- and mitoxantrone-induced cardiotoxicity (2001) (114)
Design and implementation of the North American Pediatric Cardiomyopathy Registry. (2000) (112)
The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium. (2011) (110)
Cardiac structure and function in children with human immunodeficiency virus infection treated with zidovudine. (1992) (107)
Isoproterenol-induced Cardiotoxicity in Sprague-Dawley Rats: Correlation of Reversible and Irreversible Myocardial Injury with Release of Cardiac Troponin T and Roles of iNOS in Myocardial Injury (2008) (107)
Effects of environmental exposures on the cardiovascular system: prenatal period through adolescence. (2004) (106)
Long-term effects of treatments for childhood cancers (2007) (106)
An analysis of energy-drink toxicity in the National Poison Data System (2013) (106)
Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy: results from the pediatric cardiomyopathy registry. (2014) (103)
Dilated cardiomyopathy (1992) (102)
Cardiotoxicity of Cancer Chemotherapy (2005) (102)
Disruption of healthcare: Will the COVID pandemic worsen non-COVID outcomes and disease outbreaks? (2020) (99)
Dilated cardiomyopathy in HIV-infected patients. (1998) (97)
Cost-Effectiveness of the Children's Oncology Group Long-Term Follow-up Screening Guidelines for Childhood Cancer Survivors at Risk for Treatment-Related Heart Failure (2014) (94)
Identification of human immunodeficiency virus-1 RNA and DNA in the heart of a child with cardiovascular abnormalities and congenital acquired immune deficiency syndrome. (1990) (93)
Cardiovascular disease in adult survivors of childhood cancer. (2015) (93)
Anthracycline cardiotoxicity in long-term survivors of childhood cancer (2007) (92)
Parameter Estimation in Longitudinal Studies with Outcome‐Dependent Follow‐Up (2002) (92)
Cardiovascular status of infants and children of women infected with HIV-1 (P2C2 HIV): a cohort study (2002) (88)
Cardiovascular trials in long-term survivors of childhood cancer. (2004) (87)
Relationship between body mass index and metabolic syndrome risk factors among US 8- to 14-year-olds, 1999 to 2002. (2008) (87)
The detection of viral genomes by polymerase chain reaction in the myocardium of pediatric patients with advanced HIV disease. (1999) (85)
Incidence of cardiac abnormalities in children with human immunodeficiency virus infection: The prospective P2C2 HIV study. (2002) (84)
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors (2019) (84)
Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: the prospective P2C2 HIV Multicenter Study. (2005) (83)
Early Predictors of Survival to and After Heart Transplantation in Children With Dilated Cardiomyopathy (2012) (82)
Immunoglobulins and left ventricular structure and function in pediatric HIV infection. (1995) (82)
Reliability of Multicenter Pediatric Echocardiographic Measurements of Left Ventricular Structure and Function: The Prospective P2C2 HIV Study (2001) (80)
Maternal Calcium Intake and Offspring Blood Pressure (2004) (76)
Exercise capacity in long‐term survivors of pediatric cancer: An analysis from the cardiac risk factors in childhood cancer survivors study (2013) (73)
Specific mitochondrial DNA deletions in idiopathic dilated cardiomyopathy. (1996) (72)
Changes in weight and co-morbidities among adolescents undergoing bariatric surgery: 1-year results from the Bariatric Outcomes Longitudinal Database. (2013) (71)
Cardiovascular Effects in Childhood Cancer Survivors Treated with Anthracyclines (2011) (71)
Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy. (2017) (71)
Characteristics and Determinants of Adiposity in Pediatric Cancer Survivors (2010) (69)
Maternal and infant factors associated with failure to thrive in children with vertically transmitted human immunodeficiency virus-1 infection: the prospective, P2C2 human immunodeficiency virus multicenter study. (2001) (67)
Anthracycline-related cardiotoxicity in childhood cancer survivors (2014) (67)
Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study). (2011) (65)
Cardiac Complications in Children With Human Immunodeficiency Virus Infection (1999) (65)
Late Mortality After Dexrazoxane Treatment: A Report From the Children's Oncology Group. (2015) (64)
Expected and actual case ascertainment and treatment rates for children infected with hepatitis C in Florida and the United States: epidemiologic evidence from statewide and nationwide surveys. (2012) (63)
Early alterations in heart gene expression profiles associated with doxorubicin cardiotoxicity in rats (2010) (62)
The pediatric pulmonary and cardiovascular complications of vertically transmitted human immunodeficiency virus (P2C2 HIV) infection study: design and methods. The P2C2 HIV Study Group. (1996) (62)
Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive strategies and therapies. (2013) (62)
Radiation-induced cardiovascular injury (2008) (62)
A Multifaceted Evaluation of Imatinib-induced Cardiotoxicity in the Rat (2011) (61)
Associations between neurohormonal and inflammatory activation and heart failure in children. (2008) (61)
Genetics of neonatal cardiomyopathy. (1999) (60)
Late cardiotoxicity following anthracycline therapy for childhood cancer (1998) (60)
Cardiotoxicity and Cardioprotection in Childhood Cancer (2014) (59)
A translational approach to detecting drug-induced cardiac injury with cardiac troponins: consensus and recommendations from the Cardiac Troponins Biomarker Working Group of the Health and Environmental Sciences Institute. (2009) (59)
Cardiac status of children infected with human immunodeficiency virus who are receiving long-term combination antiretroviral therapy: results from the Adolescent Master Protocol of the Multicenter Pediatric HIV/AIDS Cohort Study. (2013) (57)
Cardiac Changes Associated With Growth Hormone Therapy Among Children Treated With Anthracyclines (2005) (57)
Dexrazoxane for protection against cardiotoxic effects of anthracyclines in children. (1996) (57)
Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber ALL Consortium Protocol 87-01. (2002) (57)
Cardiac toxicity of intravenous terbutaline for the treatment of severe asthma in children: a prospective assessment. (2000) (55)
Predictors of cardiac morbidity and related mortality in children with acquired immunodeficiency syndrome. (2003) (54)
Bariatric surgery significantly decreases the prevalence of type 2 diabetes mellitus and pre-diabetes among morbidly obese multiethnic adults: long-term results. (2011) (54)
Serial measurements of serum NT-proBNP as markers of left ventricular systolic function and remodeling in children with heart failure. (2010) (54)
Outcome Predictors for Pediatric Dilated Cardiomyopathy: A Systematic Review. (2007) (54)
BMI, Waist Circumference, and Selected Cardiovascular Disease Risk Factors Among Preschool‐Age Children (2012) (53)
Risk factors for cardiovascular disease in children infected with human immunodeficiency virus-1. (2008) (53)
Treating children with idiopathic dilated cardiomyopathy (from the Pediatric Cardiomyopathy Registry). (2009) (53)
The Pediatric Cardiomyopathy Registry: 1995-2007. (2008) (53)
Managing Chemotherapy-Related Cardiotoxicity in Survivors of Childhood Cancers (2014) (53)
Cardiac effects in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents: a view from the United States of America (2013) (53)
Body mass index, waist circumference, and cardiovascular risk factors in adolescents. (2008) (53)
Non-invasive assessment of rejection in pediatric transplant patients: serologic and echocardiographic prediction of biopsy-proven myocardial rejection. (2000) (50)
Components of height and blood pressure in childhood. (2014) (49)
Are routine preoperative cardiac catheterization and angiography necessary before repair of ostium primum atrial septal defect? (1988) (49)
Ingesting and Aspirating Dry Cinnamon by Children and Adolescents: The “Cinnamon Challenge” (2013) (48)
Dietary Quality, Caloric Intake, and Adiposity of Childhood Cancer Survivors and Their Siblings: An Analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study (2013) (48)
Serum cardiac troponin and subclinical cardiac status in pediatric chronic renal failure. (2003) (48)
Cardiovascular risk factors, monitoring, and therapy for HIV-infected patients (2003) (48)
HAART to heart: highly active antiretroviral therapy and the risk of cardiovascular disease in HIV-infected or exposed children and adults (2012) (46)
A clinic-based, comprehensive care model for studying late effects in long-term survivors of pediatric illnesses. (2004) (46)
Prevalence of self-reported memory problems in adult cancer survivors: a national cross-sectional study. (2012) (46)
Cardiomyopathy caused by antineoplastic therapies (2001) (45)
Prevention of cardiotoxicity among survivors of childhood cancer (2017) (44)
Upfront dexrazoxane for the reduction of anthracycline-induced cardiotoxicity in adults with preexisting cardiomyopathy and cancer: a consecutive case series (2019) (44)
Survival Without Cardiac Transplantation Among Children With Dilated Cardiomyopathy. (2017) (44)
Cardiac structure and function in fetuses of mothers infected with HIV: the prospective PCHIV multicenter study. (2000) (43)
Chemotherapy-induced cardiotoxicity in children (2017) (43)
Nutritional status and cardiac mass and function in children infected with the human immunodeficiency virus. (1997) (43)
Increased risk of asthma and atopic dermatitis in perinatally HIV-infected children and adolescents. (2012) (42)
The complete pharmacokinetic profile of serum cardiac troponin I in the rat and the dog. (2011) (42)
Ethnic Group Differences in Cardiometabolic Disease Risk Factors Independent of Body Mass Index among American Youth (2013) (42)
Pathogenesis of HIV‐Associated Cardiomyopathy (2001) (42)
Cranial Irradiation as an Additional Risk Factor for Anthracycline Cardiotoxicity in Childhood Cancer Survivors: An Analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study (2013) (42)
A partial correlation coefficient and coefficient of determination for multivariate normal repeated measures data (2001) (41)
Frequency of elevations in markers of cardiomyocyte damage in otherwise healthy newborns. (2008) (40)
Cardiovascular disease in survivors of childhood cancer (2018) (40)
Cardiac complications in childhood cancer survivors treated with anthracyclines* (2015) (40)
Thyroid Cancer Risk 40+ Years after Irradiation for an Enlarged Thymus: An Update of the Hempelmann Cohort (2010) (40)
Aggregate Risk of Cardiovascular Disease Among Adolescents Perinatally Infected With the Human Immunodeficiency Virus (2014) (39)
Biomarkers of Vascular Dysfunction in Children Infected With Human Immunodeficiency Virus-1 (2010) (39)
Associations of cytokines, sleep patterns, and neurocognitive function in youth with HIV infection. (2012) (38)
Ventricular structure and function in children with sickle cell disease using conventional and tissue Doppler echocardiography. (2012) (38)
Alterations in Cardiac and Pulmonary Function in Pediatric Rapid Human Immunodeficiency Virus Type 1 Disease Progressors (2000) (38)
Joint generalized estimating equations for multivariate longitudinal binary outcomes with missing data: an application to acquired immune deficiency syndrome data (2009) (37)
Coronary artery calcifications in the long-term follow-up of Kawasaki disease. (2005) (37)
Association between congenital cardiovascular malformations and neuroblastoma. (2004) (37)
Dexrazoxane-associated risk for secondary malignancies in pediatric Hodgkin's disease: a claim without compelling evidence. (2007) (37)
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group V: Management of Cardiovascular-Renal Complications (2002) (37)
Myocardial and pericardial disease in HIV (2002) (36)
The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Trial (2017) (36)
Maternal protein intake is not associated with infant blood pressure. (2005) (35)
Dexrazoxane for reducing anthracycline-related cardiotoxicity in children with cancer: An update of the evidence (2014) (35)
Hearts too small for body size after doxorubicin for childhood ALL: Grinch syndrome. (2014) (34)
Associations between fibroblast growth factor 23 and cardiac characteristics in pediatric heart failure (2013) (34)
Longitudinal Studies With Outcome-Dependent Follow-up (2007) (34)
Prevalence of congenital cardiovascular malformations in children of human immunodeficiency virus-infected women: the prospective P2C2 HIV Multicenter Study. P2C2 HIV Study Group, National Heart, Lung, and Blood Institute, Bethesda, Maryland. (1998) (33)
Arrhythmias in children prenatally exposed to cocaine. (1994) (33)
Physical fitness in children infected with the human immunodeficiency virus: associations with highly active antiretroviral therapy. (2013) (33)
Cardiovascular Disease and Therapeutic Drug-Related Cardiovascular Consequences in HIV-Infected Patients (2011) (32)
Limitations of fractional shortening as an index of contractility in pediatric patients infected with human immunodeficiency virus. (1994) (32)
Late Cardiotoxicity: Issues for Childhood Cancer Survivors (2016) (32)
HIV-associated cardiovascular complications: a new challenge for emergency physicians. (2001) (32)
Exercise rehabilitation of pediatric patients with cardiovascular disease (2005) (32)
Sex-related Differences in Mast Cell Activity and Doxorubicin Toxicity (2014) (31)
Life-threatening reaction to trimethoprim/sulfamethoxazole in pediatric human immunodeficiency virus infection. (1994) (30)
Maternal calcium intake during pregnancy and blood pressure in the offspring at age 3 years: a follow-up analysis of the Project Viva cohort. (2008) (30)
Aggregating traditional cardiovascular disease risk factors to assess the cardiometabolic health of childhood cancer survivors: an analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study. (2012) (30)
Why multidisciplinary clinics should be the standard for treating chronic kidney disease (2012) (30)
Impaired mitochondrial function is abrogated by dexrazoxane in doxorubicin‐treated childhood acute lymphoblastic leukemia survivors (2016) (29)
HIV-Related Cardiovascular Disease and Drug Interactions (2004) (28)
Usefulness of the pediatric electrocardiogram in detecting left ventricular hypertrophy: results from the Prospective Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2 HIV) multicenter study. (2003) (28)
Association of Left Ventricular Dilation at Listing for Heart Transplant With Postlisting and Early Posttransplant Mortality in Children With Dilated Cardiomyopathy (2009) (28)
Myocardial Alternative RNA Splicing and Gene Expression Profiling in Early Stage Hypoplastic Left Heart Syndrome (2012) (28)
Cardiovascular disease and toxicities related to HIV infection and its therapies (2005) (28)
Pediatric Cardiomyopathy as a Chronic Disease: A Perspective on Comprehensive Care Programs. (2008) (27)
Lessons learned from the Pediatric Cardiomyopathy Registry (PCMR) Study Group* (2015) (27)
Differences in Presentation and Outcomes Between Children With Familial Dilated Cardiomyopathy and Children With Idiopathic Dilated Cardiomyopathy: A Report From the Pediatric Cardiomyopathy Registry Study Group (2017) (27)
Erratum: Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (The Lancet (2016) 388(10053) (1775–1812)(S0140673616314702)(10.1016/S0140-6736(16)31470-2)) (2017) (27)
Cardiovascular complications in patients with HIV infection (2003) (27)
Malnutrition and cardiac abnormalities in the HIV-infected patient. (1999) (26)
Cardiology in AIDS (1998) (26)
Mediators in HIV-associated cardiovascular disease: a focus on cytokines and genes. (2003) (25)
Energy drink-induced near-fatal ventricular arrhythmia prevented by an intracardiac defibrillator decades after operative "repair" of tetralogy of Fallot. (2014) (25)
Effectiveness of Bariatric Surgery in Reducing Weight and Body Mass Index Among Hispanic Adolescents (2012) (24)
Breast Cancer Risk 55+ Years After Irradiation for an Enlarged Thymus and Its Implications for Early Childhood Medical Irradiation Today (2010) (24)
Dilation of the aortic root in children infected with human immunodeficiency virus type 1: The Prospective P2C2 HIV Multicenter Study. (2001) (24)
Cardiometabolic disease in human immunodeficiency virus-infected children. (2008) (24)
Anthracycline cardiotoxicity: the importance of horizontally integrating pre-clinical and clinical research. (2018) (24)
Predicting Cardiovascular Disease Among Testicular Cancer Survivors After Modern Cisplatin‐based Chemotherapy: Application of the Framingham Risk Score (2018) (24)
Caffeine and Clinical Outcomes in Premature Neonates (2019) (24)
Cardiovascular diseases in survivors of childhood cancer (2020) (23)
An expert opinion on pharmacologic approaches to reducing the cardiotoxicity of childhood acute lymphoblastic leukemia therapies (2013) (23)
Emergence of beta-adrenergic sensitivity in the developing chicken heart. (1981) (23)
Cardiovascular Monitoring and Therapy for HIV‐Infected Patients (2001) (23)
Low dose radiation and circulatory diseases: a brief narrative review (2015) (22)
Cardiac Effects of Highly Active Antiretroviral Therapy in Perinatally HIV-Infected Children: The CHAART-2 Study. (2017) (22)
A weighted estimating equation for linear regression with missing covariate data (2002) (22)
Cardiovascular effects of HAART in infants and children of HIV-infected mothers (2007) (22)
New developments in the biochemical assessment of myocardial injury in children: troponins T and I as highly sensitive and specific markers of myocardial injury (1997) (22)
Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children’s Oncology Group (2019) (21)
Estimation in regression models for longitudinal binary data with outcome-dependent follow-up. (2005) (20)
Postmortem cardiomegaly and echocardiographic measurements of left ventricular size and function in children infected with the human immunodeficiency virus. The Prospective P2C2 HIV Multicenter Study. (2003) (20)
Pediatric metabolic syndrome: Comprehensive clinical review and related health issues (2012) (20)
Ethnic group differences in waist circumference percentiles among U.S. children and adolescents: estimates from the 1999-2008 National Health and Nutrition Examination Surveys. (2011) (19)
Electrocardiography and 24-Hour Electrocardiographic Ambulatory Recording (Holter Monitor) Studies in Children Infected with Human Immunodeficiency Virus Type 1 (2000) (19)
Associations of prenatal maternal blood mercury concentrations with early and mid-childhood blood pressure: a prospective study. (2014) (19)
Cardiac, Aortic, and Pulmonary Arteriopathy in HIV-infected children: The Prospective P2C2 HIV Multicenter Study (2004) (19)
Perinatal Factors Associated with Cardiovascular Disease Risk among Preschool-Age Children in the United States: An Analysis of 1999–2008 NHANES Data (2012) (19)
Cardiac biomarkers in HIV-exposed uninfected children (2013) (19)
The benefits and hazards of publicly reporting quality outcomes (2016) (19)
Report on the International Colloquium on Cardio-Oncology (Rome, 12–14 March 2014) (2014) (19)
Current applications and Future Needs for Biomarkers in Pediatric Cardiomyopathy and Heart Failure: Summary From The Second International Conference On Pediatric Cardiomyopathy. (2011) (18)
Beta-adrenergic adaptation in idiopathic dilated cardiomyopathy: differences between children and adults. (2014) (18)
Risk factors for early anthracycline clinical cardiotoxicity in children: the pediatric oncology group experience (1997) (18)
Baseline Serum Cardiac Troponin I Concentrations in Sprague-Dawley, Spontaneous Hypertensive, Wistar, Wistar-Kyoto, and Fisher Rats as Determined with an Ultrasensitive Immunoassay (2011) (18)
Cardiovascular Abnormalities in HIV-Infected Individuals (2012) (18)
Doxorubicin-induced cardiomyopathy. (1999) (18)
Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology Group (2021) (18)
Surgical Interventions in Infants Born Preterm with Congenital Heart Defects: An Analysis of the Kids' Inpatient Database (2017) (18)
A Report from the 2013 International Workshop: Radiation and Cardiovascular Disease, Hiroshima, Japan (2013) (18)
Cardiovascular disease in long-term survivors of pediatric Hodgkin's disease (1998) (18)
The relevance of information generated by in vitro experimental models to clinical doxorubicin cardiotoxicity (2006) (17)
The impact of heart failure severity at time of listing for cardiac transplantation on survival in pediatric cardiomyopathy. (2011) (17)
Mitochondrial function in children with idiopathic dilated cardiomyopathy (1996) (17)
Cardiac Failure 30 Years After Treatment Containing Anthracycline for Childhood Acute Lymphoblastic Leukemia (2012) (17)
The Use of Cardiac Biomarkers to Detect Myocardial Damage Induced by Chemotherapeutic Agents (2003) (16)
The Evolving Design of NIH-Funded Cardio-Oncology Studies to Address Cancer Treatment-Related Cardiovascular Toxicity (2019) (16)
Body mass index as a function of length of United States residency among Haitian immigrant children. (2010) (16)
Cardiotoxicity in childhood cancer survivors: A problem with long‐term consequences in need of early detection and prevention (2013) (16)
Serum cardiac troponin T as a biomarker for acute myocardial injury induced by low doses of isoproterenol in rats (2007) (16)
Genetic Causes of Cardiomyopathy in Children: First Results From the Pediatric Cardiomyopathy Genes Study (2021) (15)
Pediatric and congenital cardiac care: Volume 2: Quality improvement and patient safety (2015) (15)
No Obesity Paradox in Pediatric Patients With Dilated Cardiomyopathy. (2018) (15)
Changes in clinical measures of autonomic nervous system function related to cancer chemotherapy-induced nausea. (1999) (15)
Establishing norms for echocardiographic measurements of cardiovascular structures and function in children. (2005) (15)
Health-Related Quality of Life and Functional Status Are Associated with Cardiac Status and Clinical Outcome in Children with Cardiomyopathy. (2016) (15)
Preventing and Treating Anthracycline-Related Cardiotoxicity in Survivors of Childhood Cancer (2012) (15)
Frequency of clinically unsuspected myocardial injury at a children's hospital. (2006) (15)
Clinical research directions in pediatric cardiology (2009) (14)
Cardiac and inflammatory biomarkers in perinatally HIV-infected and HIV-exposed uninfected children (2018) (14)
Heart failure in childhood cancer survivors (2007) (14)
Long-Term Effects of In Utero Antiretroviral Exposure: Systolic and Diastolic Function in HIV-Exposed Uninfected Youth. (2016) (14)
Effect of ethnicity on weight loss among adolescents 1 year after bariatric surgery. (2013) (13)
Screening for long-term cardiac status during cancer treatment. (2012) (13)
Accelerated cardiovascular disease and myocardial infarction risk in patients with the human immunodeficiency virus. (2008) (13)
Cardioprotection and safety of dexrazoxane (DRZ) in children treated for newly diagnosed T-cell acute lymphoblastic leukemia (T-ALL) or advanced stage lymphoblastic leukemia (T-LL). (2012) (13)
Anthracycline-induced Cardiotoxicity: Natural History, Risk Factors, and Prevention (2008) (13)
Pediatric Dilated Cardiomyopathy (DCM): Prognosis in a developing nation is comparable to developed nations (1996) (12)
Bayesian partial linear model for skewed longitudinal data. (2015) (12)
A review of the preclinical development of dexrazoxane (2014) (12)
Cardiac Biomarkers in Pediatric Cardiomyopathy: Study Design and Recruitment Results from the Pediatric Cardiomyopathy Registry. (2019) (12)
Comment on “Dose-responses from multi-model inference for the non-cancer disease mortality of atomic bomb survivors” (Radiat. Environ. Biophys (2012) 51:165–178) by Schöllnberger et al. (2013) (12)
Declining Incidence of Systolic Left Ventricular Dysfunction in Human Immunodeficiency Virus-Infected Individuals Treated With Highly Active Antiretroviral Therapy. (2016) (12)
Circulatory disease mortality in the Massachusetts tuberculosis fluoroscopy cohort study (2016) (12)
Potential latent effects of prenatal cocaine exposure on growth and the risk of cardiovascular and metabolic disease in childhood. (2011) (11)
The effects of dexrazoxane on cardiac status and second malignant neoplasms (SMN) in doxorubicin-treated patients with osteosarcoma (OS). (2012) (11)
Pediatric HIV/AIDS Cohort Study (PHACS) Adolescent Master Protocol (AMP) Protocol PH 200 (2010) (11)
Pediatric and congenital cardiac care: Volume 1: Outcomes analysis (2015) (11)
904-53 Left Ventricular Structure and Function Eleven Years After Doxorubicin Treatment for Childhood Leukemia: Is this a Restrictive Cardiomyopathic Process? (1995) (11)
Chronic kidney disease and cardiac morbidity — What are the possible links? (2016) (10)
Cardiovascular outcomes of pediatric seroreverters perinatally exposed to HAART (2007) (10)
Joint generalized estimating equations for multivariate longitudinal binary outcomes with missing data: An application to AIDS data. (2009) (10)
Left ventricle segmental function in childhood cancer survivors using speckle-tracking echocardiography (2019) (10)
Issues in solid-organ transplantation in children: translational research from bench to bedside (2014) (10)
Frequent Mitochondrial DNA Mutations and Polymorphisms in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia. (2007) (10)
Late effects of therapy for Hodgkin’s lymphoma (2007) (9)
The genetic architecture of pediatric cardiomyopathy (2022) (9)
Left ventricular diastolic dysfunction in HIV-uninfected infants exposed in utero to antiretroviral therapy. (2019) (9)
The Effects of Fetal and Childhood Exposure to Antiretroviral Agents (2012) (9)
Realizing optimal care for children with cardiovascular disease: Funding challenges and research approaches (2005) (9)
Wise up: Do not do it without protection! (2005) (9)
The cardiovascular manifestations of HIV infections (2007) (9)
Ischemic heart disease after breast cancer radiotherapy. (2013) (9)
Letter by Lipshultz Regarding Article, "Anthracycline Cardiotoxicity: Worrisome Enough to Have You Quaking?" (2018) (9)
The Influence of Age on Serum Concentrations of Cardiac Troponin I (2014) (9)
Reduction in cardiometabolic disease risk following gastric bypass surgery among Hispanic adults. (2013) (8)
Readmitting Children with Heart Failure: the Importance of Communication, Coordination, and Continuity of Care. (2016) (8)
Myocardial Mononuclear Cell Infiltrates Are Not Associated with Increased Serum Cardiac Troponin I in Cynomolgus Monkeys (2012) (8)
Short- and long-term safety and efficacy of bariatric surgery for severely obese adolescents: a narrative review (2019) (8)
Effect of Dexrazoxane on Heart Function Among Long-Term Survivors of Childhood Leukemia and Lymphoma: A Report from the Children's Oncology Group (COG) (2016) (8)
Ethical issues in children with cardiomyopathy: Making sense of ethical challenges in the clinical setting (2007) (8)
Obesity and length of hospital stay in children: A retrospective review of Florida Agency for Health Care Administration data (2011) (8)
Can the consequences of universal cholesterol screening during childhood prevent cardiovascular disease and thus reduce long-term health care costs? (2012) (8)
Summary of the 2015 International Paediatric Heart Failure Summit of Johns Hopkins All Children’s Heart Institute (2015) (8)
Epidemiological and Outcomes Research in Children with Pediatric Cardiomyopathy: Discussions from the International Workshop on Primary and Idiopathic Cardiomyopathies in Children. (2008) (8)
Abstract 4038: Antiretroviral Therapy (ART) Cardiac Effects in HIV-Infected Children: The Multicenter NHLBI Cardiac Highly Active Antiretroviral Therapy (CHAART-II) Study (2009) (8)
The danger of relying on the interpretation of p-values in single studies: Irreproducibility of results from clinical studies (2017) (8)
Cardiac status of perinatally HIV-infected children: assessing combination antiretroviral regimens in observational studies (2018) (7)
Rethinking COVID-19 in children: Lessons learned from pediatric viral and inflammatory cardiovascular diseases (2020) (7)
The utility of serum biomarkers to detect myocardial alterations induced by Imatinib in rats (2014) (7)
Nutritional supplement (2020) (7)
Cardiomyocyte injury to transplant: pediatric management (2003) (7)
Cardiovascular manifestations of pediatric HIV infection. (1995) (7)
Balancing the oncologic effectiveness versus the cardiotoxicity of anthracycline chemotherapy in childhood cancer (2014) (7)
Cardiotoxicity caused by chemotherapy (2003) (7)
Abstract 16673: Exome Sequencing in a Pediatric Cardiomyopathy Cohort: Findings From the Pediatric Cardiomyopathy Registry (2017) (6)
Diagnosis and screening of hypertrophic cardiomyopathy in children (2011) (6)
Peak oxygen consumption in Hodgkin's lymphoma survivors treated with mediastinal radiotherapy as a predictor of quality of life 5years later (2015) (6)
Cardiotoxic Effects of Radiation Therapy in Hodgkin’s Lymphoma and Breast Cancer Survivors and the Potential Mitigating Effects of Exercise (2008) (6)
The Relationship of Childhood Obesity with Cardiomyopathy and Heart Failure (2012) (6)
Prenatal Cocaine Exposure and Cardiometabolic Disease Risk Factors in 18- to 20-Year-Old African Americans. (2015) (5)
Evaluation of coxsackievirus infection in children with human immunodeficiency virus type 1-associated cardiomyopathy. (2002) (5)
Elevated Heart Rate and Survival in Children With Dilated Cardiomyopathy: A Multicenter Study From the Pediatric Cardiomyopathy Registry (2020) (5)
Late mortality and relapse after dexrazoxane (DRZ) treatment: An update from the Children’s Oncology Group (COG). (2014) (5)
Cardiometabolic risk in childhood cancer survivors: a report from the Children's Oncology Group. (2021) (5)
Left ventricular dysfunction in infants and children infected with the human immunodeficiency virus (1997) (5)
Fertility, Cardiac, and Orthopedic Challenges in Survivors of Adult and Childhood Sarcoma. (2017) (5)
Cardiotoxicity in Childhood Cancer Survivors (2012) (5)
Radiation-associated risk factors for premature cardiovascular disease in childhood cancer survivors include accelerated atherosclerosis (2003) (5)
Epidemiology and global burden of cardiomyopathy (2018) (5)
Assessing Latent Effects of Prenatal Cocaine Exposure on Growth and Risk of Cardiometabolic Disease in Late Adolescence: Design and Methods (2012) (5)
Enhancing quality of life as a goal for anticancer therapeutics (2016) (5)
Cardiovascular Effects of Cancer Therapy (2015) (5)
Abstract 16801: Improved Transplant-Free Survival of Children With Dilated Cardiomyopathy: Analysis of Two Decades From the Pediatric Cardiomyopathy Registry (2014) (5)
Does Lowering Heart Rate Improve Outcomes in Children With Dilated Cardiomyopathy and Chronic Heart Failure? (2017) (4)
Pediatric case of the day. Cardiac hemangioma. (1991) (4)
Anthracycline cardiotoxicity in survivors of childhood cancer: Clinical course, protection, and treatment (2014) (4)
CARDIOVASCULAR SIGNALING PROTEINS AS PREDICTORS OF DOXORUBICIN-RELATED CARDIAC EFFECTS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA (2018) (4)
Cardiovascular Complications of HIV infection in Children (1995) (4)
Exercise capacity in long-term survivors of pediatric cancer. (2016) (4)
Gender is a factor that can impact the severity of doxorubicin (DXR) toxicity in spontaneously hypertensive rats (SHR) (2008) (4)
Cardiovascular Toxicity of Antitumor Drugs: Dimensions of the Problem in Children (2010) (4)
Efficacy of the Children's Oncology Group (COG) long-term follow-up (LTFU) guidelines in reducing risk of congestive heart failure (CHF) in childhood cancer survivors (CCS). (2012) (4)
Cardiotoxicity in pediatric lymphoma survivors (2021) (4)
Associations between neurohormonal and inflammatory activation and heart failure in children (2007) (4)
Agreement Between Two Ratings with Different Ordinal Scales (2007) (4)
Mid-ventricular obstructive hypertrophic cardiomyopathy during pregnancy complicated by preeclampsia and acute myocardial infarction: a case report. (2011) (4)
Ingesting and aspirating dry cinnamon by children and adolescents: The "cinnamon challenge" (2014) (4)
Abstract 3356: Outcome and Risk Stratification for Children With Left Ventricular Noncompaction: Findings From the Pediatric Cardiomyopathy Registry (2009) (4)
Five-year outcomes after regionalizing pediatric cardiac surgery centers (2018) (4)
Exact Bayesian p-values for a test of independence in a 2 × 2 contingency table with missing data (2018) (4)
Does Clinically Unsuspected Myocardial Injury Occur in Children? † 589 (1997) (3)
A High School-Based Voluntary Cardiovascular Risk Screening Program: Issues of Feasibility and Correlates of Electrocardiographic Outcomes (2013) (3)
Cardiovascular Effects of Anthracycline Chemotherapy and Radiation Therapy in Children with Cancer (2016) (3)
Abstract 2556: A Comparative Analysis of Outcomes for Pediatric Patients with Biopsy-Proven Myocarditis, Clinically-Diagnosed Myocarditis and Idiopathic Dilated Cardiomyopathy. (2007) (3)
Outcome of Dana-Farber Cancer Institute (DFCI) Consortium Protocol 95–01 for Children with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL). (2004) (3)
Markers of Bone Mineral Metabolism and Cardiac Structure and Function in Perinatally HIV-Infected and HIV-Exposed but Uninfected Children and Adolescents (2019) (3)
Stakeholder perspectives on addressing adverse events from adjuvant cancer therapy: A qualitative study (2019) (3)
Assessing the global and regional impact of primary cardiomyopathies: The Global Burden of Diseases, Injuries and Risk Factors (GBD 2010) Study (2011) (3)
Regional sharing optimizes arterial switch outcomes (2005) (3)
Estimating Risk of Circulatory Disease: Little et al. Respond (2012) (3)
An Invitation from the Editors of Cardio-Oncology (2015) (3)
Abstract 6071: Phenotypic Heterogeneity and Outcomes of Restrictive Cardiomyopathy in Childhood - A Report from the NHLBI Pediatric Cardiomyopathy Registry (2008) (3)
Idiopathic and Primary Cardiomyopathies in Children. (2007) (3)
Abstract 10808: Left Ventricular Diastolic Dysfunction in HIV-Negative Infants Exposed In Utero to Antiretroviral Therapy from HIV-Positive Mothers: The Prospective NHLBI CHAART-I Study (2011) (3)
Prevalence of the Metabolic Syndrome in US Youth (2019) (3)
Pediatric AIDS: Clinical, Pathologic, and Basic Science Perspectives. Conference proceedings. Washington, D.C., November 18-21, 1992. (1993) (3)
GENETIC AND VIRAL GENOME ANALYSIS OF CHILDHOOD CARDIOMYOPATHY: THE PCMR/PCSR EXPERIENCE (2010) (3)
Preventing pediatric cardiomyopathy: a 2015 outlook (2016) (3)
Effect of dexraoxane on impaired mitochondrial structure and function in doxorubicin-treated childhood ALL survivors. (2012) (3)
Screening for Cardiovascular Disease in Survivors of Thoracic Radiation (2008) (3)
Outcomes analysis, quality improvement, and patient safety for pediatric and congenital cardiac care: Theory, implementation, and applications (2011) (3)
Cardiac management by pediatricians versus pediatric cardiologists in an inpatient academic center. (2003) (3)
PROGRESSIVE LEFT VENTRICULAR CHANGES PREDICT THE LIKELIHOOD OF SURVIVAL IN PEDIATRIC DILATED CARDIOMYOPATHY: FINDINGS FROM THE PEDIATRIC CARDIOMYOPATHY REGISTRY (2012) (3)
Abstract 4956: A Risk Stratification Analysis of Predictors of Death or Transplant in Children with Hypertrophic Cardiomyopathy (2008) (3)
Abstract 2557: Clinical Factors Associated with UNOS Status and Outcome After Listing for Heart Transplant in Children with Dilated Cardiomyopathy (2007) (3)
Building a pediatric clinical research division. (2008) (3)
Introduction for "Idiopathic and Primary Cardiomyopathy in Children" (2007) (3)
Do selection criteria for children with dilated cardiomyopathy enrolled in national registries explain differences in outcomes (2014) (3)
Long-Term Outcomes after Adolescent Bariatric Surgery. (2022) (2)
In reply to “Interpretation of ‘An analysis of energy-drink toxicity in the National Poison Data System’” (2014) (2)
Relation between Serum Troponin Levels and Cardiovascular Status in Children and Young Adults with Chronic Renal Failure (1999) (2)
Cardiac Emergencies in Children (2018) (2)
Cardiac status predicts quality of life in Hodgkin's disease survivors. (2006) (2)
LV structure, LV function, and serum NT-proBNP in childhood cancer survivors without anthracycline or cardiac radiation exposures (2011) (2)
Cardiac effects of growth hormone treatment in pediatric populations (2012) (2)
Etiology and family history of pediatric cardiomyopathy: the early pediatric cardiomyopathy registry (PCMR) experience (1998) (2)
Training pediatric cardiologists to meet the needs of patients with neurodevelopmental disorders (2017) (2)
Late cardiac status in long-term survivors of childhood high-risk ALL 8 years after continuous or bolus infusion of doxorubicin: The DFCI Childhood ALL 91-01 randomized trial. (2010) (2)
Erratum: Pathogenesis of HIV-associated cardiovascular complications (Lancet Infections Diseases (2004) 1 (115-124)) (2004) (2)
901-105 Cardiac Structure and Function in Fetuses of Human Immunodeficiency Virus (HIV)-Infected Mothers: The Prospective NHLBI P2C2 Study (1995) (2)
Fertility, Cardiac, and Orthopedic Challenges in Survivors of Adult and Childhood Sarcoma. (2017) (2)
Lowering the P Value Threshold. (2018) (2)
Effects of Metabolic Syndrome on Atherosclerosis in Childhood (2012) (2)
Introduction: Idiopathic and primary cardiomyopathies in children (2008) (2)
Abstract 19842: Laparoscopic Gastric Bypass Surgery and Adjustable Gastric Banding Significantly Improves Cardiometabolic Disease Risk Among Morbidly Obese Multiethnic Adolescents (2010) (2)
965Increased heart rate is independently associated with worse survival in pediatric patients with dilated cardiomyopathy: a multicenter study from the pediatric cardiomyopathy registry (2017) (2)
Risk of coronary events 55 Years after Thymic irradiation in the Hempelmann cohort (2018) (2)
30-year risk of myocardial infarction, stroke, or coronary death in childhood cancer survivors. (2010) (2)
Abstract 20432: Diagnostic Value of Cardiac Troponin T, N-Terminal Pro-Brain Natriuretic Peptide, and High-Sensitivity C-Reactive Protein During Doxorubicin Therapy in Children with Acute Lymphoblastic Leukemia (2010) (2)
Heart failure in childhood cancer survivors (2007) (2)
Cardiac structure and function in fetuses of mothers infected with HIV: The prospective P 2 C 2 HIV multicenter study (2011) (2)
Abstract 3793: Nutritional Status is Associated With Cardiac Outcomes and Mortality in Children With Idiopathic Dilated Cardiomyopathy (2009) (2)
Abstract 4037: Increased Left Ventricular and Aortic Dimensions in Long-Term Multiagent Antiretroviral Therapy (ART)-Treated HIV-Infected Children: The NIH Multicenter Pediatric HIV/AIDS Cohort Study (PHACS) (2009) (2)
A Randomized Controlled Laboratory Study on the Long-Term Effects of Methylphenidate on Cardiovascular Function and Structure in Rhesus Monkeys (2018) (2)
Training pediatric cardiologists to meet the needs of patients with neurodevelopmental disorders (2017) (2)
The Incidence of Pediatric Cardiomyopathy in the NHLBI Pediatric Cardiomyopathy Registry (1999) (1)
Abstract 2343: Outcomes in Children with Noonan Syndrome and Cardiomyopathy (2007) (1)
THE CARDIAC BIOMARKERS IN CHILDREN WITH CARDIOMYOPATHY MULTICENTER STUDY: PRELIMINARY RESULTS FOR PEDIATRIC HYPERTROPHIC CARDIOMYOPATHY (2016) (1)
Anthracycline, Herceptin, and CV Toxicity (2010) (1)
Viral Load and CD4 T Cell Percentage Predict Sleep Disturbances in HIV-Infected Children (2009) (1)
Abstract 14210: Phenotype, but Not Genotype, Determines Survival in Pediatric Dilated Cardiomyopathy: A Study From the NHLBI-Funded Pediatric Cardiomyopathy Registry (2018) (1)
Abstract 16026: Association of Cardiac Structure and Function with In Utero Antiretroviral Exposure Among Uninfected Children Born to HIV-Infected Mothers in the Pediatric HIV/AIDS Cohort Study (2010) (1)
Abstract 16092: Outcomes in Children with Familial Dilated Cardiomyopathy Compared to Children with Idiopathic Dilated Cardiomyopathy (2010) (1)
T.18. Circadian Regulation of IL-6, IL-1β and IL-1RA Levels is Disrupted in HIV-infected Children (2009) (1)
Candidate serum biomarkers of doxorubicin-induced cardiotoxicity in pediatric acute lymphoblastic leukemia assessed by nanoparticle-capture mass spectrometry. (2010) (1)
Development and pilot evaluation of a new nanoparticle-capture workflow for doxorubicin-induced toxicity biomarker identification (2015) (1)
Department of Error (2017) (1)
Anthracycline cardiotoxicity in a childhood cancer survivor: A case report and review (2006) (1)
CROSS VALIDATION OF NT-PROBNP AS A PREDICTOR OF CARDIAC TRANSPLANT IN CHILDREN WITH DILATED CARDIOMYOPATHY (2011) (1)
Corrigendum to “Regional sharing optimizes arterial switch outcomes” [Prog. Pediatr. Cardiol. 20 (2005) 21–25] (2005) (1)
The Value of National Institutes of Health (NIH) Registry-Based Research in Identifying Childhood Cardiac Disease Outcomes: The Pediatric Cardiomyopathy Registry Experience (2015) (1)
The implication of coronary artery malformations and congenital heart disease on cardiomyopathy (2014) (1)
Cardiac toxicity of mediastinal radiotherapy : Which are the critical structures? (2005) (1)
Abstract 4953: The Impact of Heart Failure Severity at Time of Listing for Cardiac Transplantation on Short and Long Term Stability with Pediatric Cardiomyopathy (2008) (1)
Corrigendum to “Peak oxygen consumption in Hodgkin's lymphoma survivors treated with mediastinal radiotherapy as a predictor of quality of life 5 years later” [Prog. Pediatr. Cardiol. 39/2PA (2015) 93–98] (2016) (1)
Prevalence of the Metabolic Syndrome in U.S. Youth (2011) (1)
Risk of atherosclerotic disease coronary artery lesions in childhood cancer survivors. (2010) (1)
Cardiomyopathy in children: importance of aetiology in prognosis – Authors' reply (2014) (1)
THE FREQUENCY OF MUTATIONS IN KNOWN CARDIOMYOPATHY GENES AMONG CHILDREN WITH HYPERTROPHIC CARDIOMYOPATHY: THE NATIONAL HEART, LUNG AND BLOOD INSTITUTE-FUNDED MULTICENTER PEDIATRIC CARDIOMYOPATHY REGISTRY STUDY (2018) (1)
Prevalence of memory problems that limit daily functioning in adult cancer patients: A national representative sample of the U.S. population. (2010) (1)
Dexrazoxane and heart function among long-term childhood cancer survivors: A Children’s Oncology Group study. (2020) (1)
Drug‐Induced Mitochondrial Cardiomyopathy and Cardiovascular Risks in Children (2018) (1)
Heart Failure in Pediatric Oncologic Disease (2017) (1)
Elevated CK-MB Does Not Reliably Indicate Myocardial Injury During Intravenous Terbutaline Therapy for the Treatment of Status Asthmaticus† 186 (1998) (1)
NEPS (2020) (1)
Utilization and Safety of Long-Term Carvedilol in Pediatric Dilated Cardiomyopathy: A Multicenter Study from the Pediatric Cardiomyopathy Registry (2016) (1)
Abstract 2550: N-terminal Pro-brain Natriuretic Peptide-defined Cardiomyopathy in Doxorubicin-treated Children with Acute Lymphoblastic Leukemia (2007) (1)
Negative Emotionality (2020) (1)
Abstract 16468: Results of Research Genetic Testing in Pediatric Cardiomyopathy Patients Justify Broader Clinical Genetic Testing (2015) (1)
Heart Failure with Preserved Ejection Fraction in Children (2022) (1)
Future research directions in pediatric cardiomyopathy (2016) (1)
IL-1β and IL-6 Levels and Sleep Patterns in HIV-Infected Children with Viremia (2008) (1)
Dexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer (2023) (1)
Predictors of bone mineral density in pediatric cancer survivors (2005) (1)
Pediatric and adult dilated cardiomyopathy are distinguished by distinct biomarker profiles (2021) (1)
We declare that we have no competing interests. (2014) (1)
Development of β adrenergic sensitivity in cultured chick cardiac muscle cells (1975) (1)
Optimizing arterial switch outcomes in medium-sized programs by regional sharing (2003) (1)
How do we improve the long-term consequences of cardiotoxicity in survivors of childhood cancer? (2014) (1)
Cardiac Effects of Growth Hormone Therapy in Children with Left Ventricular Dysfunction (1999) (1)
Incidence of and Risk Factors for Sudden Cardiac Death in Children With Dilated Cardiomyopathy (2012) (1)
Complete dexrazoxane cardioprotection for cardiac function but incomplete female cardioprotection for cardiac structure in doxorubicin-treated osteosarcoma survivors: Hearts too small for the body. (2017) (0)
Cardiotoxicity After Childhood Cancer Treatment (2020) (0)
Occult myocardial injury in otherwise healthy newborns (2003) (0)
Heart Failure (2016) (0)
Cell Transplantation and Fibrin Matrix (2016) (0)
Identification of the X-Linked Infantile Spinal Muscular Atrophy ( XL-SMA ) Gene : Insights into Pathogenesis (2010) (0)
Abstract 13179: Distinct Biomarker Profiles for Pediatric and Adult Dilated Cardiomyopathy (2020) (0)
Epilogue –A Vision for the Future (2015) (0)
Lessons from the hearts of survivors of childhood cancer (2014) (0)
Summary Increase Quality of Care for Patients Living With HIV/AIDS: Executive State of the Science Conference: Initiative to Decrease Cardiovascular Risk and (2008) (0)
Cancer Treatment-Related Cardiotoxicities (2005) (0)
505: Prognostic Value of Serial Measurements of NT-proBNP in Children with Heart Failure (2008) (0)
Lipid Abnormalities (2016) (0)
Dexrazoxane is cardioprotective against doxorubicin cardiotoxicity (2002) (0)
Etiology and Family History of Pediatric Cardiomyopathy: The Early Pediatric Cardiomyopathy Registry (PCMR) Experience • 125 (1998) (0)
High Blood Pressure (2015) (0)
Abstract 16563: Fibrosis and Hypertrophy Assessed by Magnetic Resonance Imaging (MRI) and Serum Biomarkers in Pediatric Hypertrophic Cardiomyopathy (HCM). A Report From the Pediatric Cardiomyopathy Registry Group (2017) (0)
Hypertensive Rats Sex-related Differences in Mast Cell Activity and Doxorubicin Toxicity : A Study in Spontaneously (2014) (0)
Low birth weight and blood pressure: The role of neonatal factors in the small-baby-syndrome . Authors'reply (2005) (0)
Book Review Viral Infections of the Heart Edited by J.E. Banatvala. 257 pp., illustrated. London, Edward Arnold, 1993. $85. 0-340-55737-0 (1994) (0)
and CardiometaboliC disease risk FaCtors in 18- to 20-Year-old (2015) (0)
Abstract 6073: Dexrazoxane Cardioprotection in Doxorubicin-Treated Children with Acute Lymphoblastic Leukemia: Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocol 95-01 Randomized Controlled Trial (2008) (0)
Development of β adrenergic sensitivity in cultured cardiac muscle cells by a high molecular weight factor from embryo extract (1976) (0)
Childhood Metabolic Syndrome and Cancer Risk (2012) (0)
Abstract 3037: Sudden Death in 1803 Children With Dilated Cardiomyopathy: Rates and Risk Factors (2009) (0)
Risk Factors for Cardiovascular Disease in Human Immunodeficiency Virus-1 Infected Children (2008) (0)
Cardiac radiation dose in pediatric cancer patients is associated with tricuspid regurgitation and decreased left ventricular wall thickness (2004) (0)
In reply [4] (2005) (0)
Evidence-based, safety management policies for pediatric cardiac care in New York State (2019) (0)
Abstract 16472: Cardiac Biomarkers Are Associated With Death and Listing for Heart Transplantation in Pediatric Patients With Newly Diagnosed Dilated Cardiomyopathy: A Multi-Center Study From the Pediatric Cardiomyopathy Registry (2017) (0)
Cardiometabolic risk in childhood cancer survivors: A Children's Oncology Group study. (2018) (0)
Analysis of myocardial fibrosis in children with hypertrophic cardiomyopathy: A report from the pediatric cardiomyopathy registry (2017) (0)
Free Radical Scavenger Protects Heart from Adriamycin Toxicity (2004) (0)
High risk of cardiovascular damage in Hodgkin’s disease survivors (1993) (0)
Abstract 18858: Spectrum of Gene Mutations in Pediatric Hypertrophic Cardiomyopathy (2016) (0)
Abstract 20165: Laparoscopic Gastric Bypass Surgery and Adjustable Gastric Banding Significantly Improves Cardiometabolic Disease Risk Among Morbidly Obese Hispanic Adults (2010) (0)
The Second Special Cardio-Oncology Issue of Progress in Pediatric Cardiology: Closing remarks and hopes for the future (2015) (0)
Progress in Pediatric Cardiology: Introduction (2003) (0)
Baseline serum cardiac troponin I concentrations in various strains of rats as determined with an ultrasensitive immunoassay (2011) (0)
Prevalence of Congenital Cardiovascular Malformations in Children of Human Immunodeﬁciency Virus-Infected Women The Prospective P 2 C 2 HIV Multicenter Study (2016) (0)
serum of rats after stressful, prolonged intense exercise Cardiac troponin T alterations in myocardium and (2015) (0)
Preface - pediatric graduate medical education (2017) (0)
Abstract 9783: Echocardiographic Normalization in Children With Idiopathic Dilated Cardiomyopathy: Results From the Pediatric Cardiomyopathy Registry (2013) (0)
Predictors of cardiac mortality and related morbidity in children with acquired immunodeficiency syndrome (2003) (0)
Long-Term E nalapril T herapy f or L eft V entricular D ysfunction in D oxorubicin-Trea ted S urvivors o f C hildhood C ancer (2002) (0)
Growth And Cardiometabolic Risk Among In Uteri Drug Exposed Adolescents (2009) (0)
AIDS and Cardiac Disease in Children Predictors of Cardiac Morbidity and Related Mortality in Children With Acquired Immunodeficiency Syndrome (2016) (0)
High Blood Pressure in Infants, Children, and Adolescents (2008) (0)
Abstract 14841: Energy Drink Exposures in the National Poison Data System: Epidemiology and Clinical Effects (2014) (0)
Neuroimmunomodulation (2004) (0)
Evaluation of imatinib (Imb)‐induced cardiotoxicity in the spontaneously hypertensive rat (SHR) (2009) (0)
Late Cardiac Effects in Childhood Cancer Survivors (2017) (0)
Introduction (2018) (0)
Abstract P012: Cardiac Biomarkers of Newborn Myocardial Injury, Cardiomyopathy and Inflammation are Associated with Indicators of Premature Cardiovascular Disease in Childhood: The National Institutes of Health Project VIVA Study (2012) (0)
Cardiovascular diseases in survivors of childhood cancer (2020) (0)
Cardiac Emergencies in Children: A Practical Approach to Diagnosis and Management (2018) (0)
Preventive Cardiology (2008) (0)
and Research Directions: A Scientific Statement From the American Heart Association Prevention, Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who (2013) (0)
Abstract P367: Caloric Intake, Dietary Quality, and Adiposity of Childhood Cancer Survivors and Their Siblings (2012) (0)
Effect of in vitro conditions on adrenergic sensitivity and intracellular cAMP in developing cardiac muscle cells (1976) (0)
Cardiac troponin T as a biomarker for monitoring chronic doxorubicin cardiomypathy (1999) (0)
The Association of Carvedilol Use on Transplant Free Survival in Pediatric Patients with Dilated Cardiomyopathy: An Analysis from the Pediatric Cardiomyopathy Registry (2017) (0)
Cancer-related memory problems, demographic, and socioeconomic backgrounds: A cross-sectional study of the United States population. (2011) (0)
Declining Incidence of Systolic Left Ventricular Dysfunction in HIV-Infected Individuals Treated with Highly Active Antiretroviral Therapy (2016) (0)
Left Ventricular Noncompaction: Evidence for a Mitochondrial Etiology (1998) (0)
for children with acute lymphoblastic leukemia Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 (2013) (0)
Pediatric Cardiomyopathy Registry Idiopathic Dilated Cardiomyopathy in Childhood: An Outcomes Study from the Ventricular Remodeling and Survival are More Favorable for Myocarditis Than For (2010) (0)
Contents Vol. 132, 2014 (2014) (0)
Maternal age and newborn blood pressure (2001) (0)
Relationship of NT-proBNP to All-Cause Death and Heart Transplant in Children with Ventricular Dysfunction and Compared to Adults with Heart Failure (2022) (0)
Abstract 16567: Are Echocardiogram and Magnetic Resonance Imaging (MRI) Comparable in Measuring Maximal Septal Thickness in Children With Hypertrophic Cardiomyopathy (HCM)? (2017) (0)
Nutritional Status and Cardiac Mass and Function in Children Infected with the Human Immunodeficiency Virus. ♦ 498 (1997) (0)
Proceedings of 2015 Innovations in Pediatric Heart Failure Symposium (2016) (0)
Textbook of Pediatric HIV Care: Cardiac problems (2005) (0)
Erratum: Heart failure in childhood cancer survivors (Nature Clinical Practice Oncology (2007) vol. 4 (334-335) doi:10.1038/ncponc0818) (2007) (0)
1164-126 Characteristics of Duchenne and Becker muscular dystrophy patients in the pediatric cardiomyopathy registry (2004) (0)
Dilated Cardiomyopathy : Results From the Pediatric Cardiomyopathy Registry Competing Risks for Death and Cardiac Transplantation in Children (2011) (0)
Moving Forward in Pediatric Heart Failure: The Need for Cross-Fertilization Between Congenital Heart Disease and Cardiomyopathies (2018) (0)
Introduction to 5th International Conference on Cardiomyopathy in Children Special Issue I (2021) (0)
ASSOCIATION OF CLINICAL OUTCOMES WITH SOCIAL VULNERABILITY IN CHILDREN WITH DILATED CARDIOMYOPATHY (2021) (0)
Abstract 3584: Comparison of the severity of imatinib-induced cardiotoxicity in normotensive Sprague-Dawley (SD) and spontaneously hypertensive (SHR) rats (2010) (0)
National Children’s Study (2020) (0)
Distinction of Serum Biomarker Profiles between Adults and Children with Dilated Cardiomyopathy (2019) (0)
Association of Human Immunodeficiency Virus Infection with Exposure to Highly Active Antiretroviral Therapy and Its Adverse Cardiovascular Effects (2015) (0)
Comment on “Dose-responses from multi-model inference for the non-cancer disease mortality of atomic bomb survivors” (Radiat. Environ. Biophys (2012) 51:165–178) by Schöllnberger et al. (2013) (0)
An improved estimator for the hydration of fat-free mass from in vivo measurements subject to additive technical errors (2010) (0)
Numerical approximations in weighted estimating equations for regression models with missing continuous covariates (2009) (0)
Eligibility for Cardiac Resynchronization Therapy for Systolic Heart Failure in Children With Cardiomyopathy (2015) (0)
When is early septal myectomy in children with hypertrophic cardiomyopathy justified? (2018) (0)
Letter to the Editor (1994) (0)
Abstract 10895: The Association of Growth Patterns and Clinical Outcomes in Children With Dilated Cardiomyopathy: A Report From the Pediatric Cardiomyopathy Registry Study Group (2015) (0)
Abstract 10262: Cranial Irradiation: A Novel Risk Factor For Anthracycline Cardiotoxicity in Childhood Cancer Survivors (2010) (0)
Progress in Pediatric Cardiology (2014) (0)
Clinically Occult Cardiac Abnormalities in Acutely III Children (1999) (0)
Coronary heart disease 55+ years after lower-dose thoracic irradiation: Preliminary results. (2010) (0)
Factors Associated With an Abnormal Blood Pressure Response During Exercise After Coarctation Repair (2021) (0)
New frontiers in Cardio-Oncology (2014) (0)
Anthracycline, Trastuzumab, and Cardiovascular Toxicity (2018) (0)
racteristics and Determinants of Adiposity B & P ediatric Cancer Survivors (2010) (0)
Immunodeficiency Virus Type 1 Disease Progressors Alterations in Cardiac and Pulmonary Function in Pediatric Rapid Human (2013) (0)
Normalization of left ventricular size and systolic function after diagnosis of pediatric dilated cardiomyopathy (2003) (0)
Systematic Review and Meta-analysis of Circula tory Disease from Exposure to Low-Level Ionizing Radia tion and Estimates of Potential Popula tion Mortality Risks (0)
Emergence of ji-adrenergic sensitivity in the developing chicken heart ( differentiation / hormone receptors / cardiac muscle cells / cyclic AMP / embryo extract ) (2003) (0)
Contributors (2019) (0)
Treatment o f C hildhood A cute L ymphoblastic L eukemia: Results o f D ana-Farber A LL C onsortium P rotocol 8 7-01 (2002) (0)
AB034. The danger of relying on the interpretation of P values in single studies: irreproducibility of results from clinical studies (2020) (0)
Differences in Cardiac Management of Children by Pediatricians and Pediatric Cardiologists. † 526 (1997) (0)
Erratum: Correction to Lancet HIV ((2016) 3 (e361–87)(S235230181630087X)(10.1016/S2352-3018(16)30087-X) (2016) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Stephen E. Lipshultz?

Stephen E. Lipshultz is affiliated with the following schools: